GT200600174A - Pirrolopiridinas sustituidas, composiciones que las contienen, proceso de fabricacion y utilizacion - Google Patents
Pirrolopiridinas sustituidas, composiciones que las contienen, proceso de fabricacion y utilizacionInfo
- Publication number
- GT200600174A GT200600174A GT200600174A GT200600174A GT200600174A GT 200600174 A GT200600174 A GT 200600174A GT 200600174 A GT200600174 A GT 200600174A GT 200600174 A GT200600174 A GT 200600174A GT 200600174 A GT200600174 A GT 200600174A
- Authority
- GT
- Guatemala
- Prior art keywords
- pirrolopiridins
- compositions
- replaced
- contain
- manufacturing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
LA PRESENTE INVENCIÓN SE REFIERE A COMPUESTOS DE LA FÓRMULA GENERAL I EN LA QUE A,L,AR,RA,Z,Y,W,R1, SON GRUPOS FUNCIONALES DESCRITOS EN EL EXPEDIENTE. ESTOS COMPUESTOS SON PIRROLOPIRIDINAS SUSTITUÍDAS QUE PRESENTAN ACTIVIDAD ANTICANCERÍGENA, MEDIANTE LA MODULACIÓN DE LA ACTIVIDAD DE PROTEÍNAS, EN ESPECIAL DE QUINASAS.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0504173A FR2884821B1 (fr) | 2005-04-26 | 2005-04-26 | Pyrrolopyridines substitues, compositions les contenant, procede de fabrication et utilisation |
Publications (1)
Publication Number | Publication Date |
---|---|
GT200600174A true GT200600174A (es) | 2006-12-26 |
Family
ID=35517344
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT200600174A GT200600174A (es) | 2005-04-26 | 2006-04-26 | Pirrolopiridinas sustituidas, composiciones que las contienen, proceso de fabricacion y utilizacion |
Country Status (33)
Country | Link |
---|---|
US (1) | US7947706B2 (es) |
EP (1) | EP1877409B1 (es) |
JP (1) | JP2008539211A (es) |
KR (1) | KR20080007229A (es) |
CN (1) | CN101166739A (es) |
AR (1) | AR061386A1 (es) |
AT (1) | ATE433976T1 (es) |
AU (1) | AU2006239105A1 (es) |
BR (1) | BRPI0613161A2 (es) |
CA (1) | CA2605744A1 (es) |
CR (1) | CR9463A (es) |
CY (1) | CY1109369T1 (es) |
DE (1) | DE602006007337D1 (es) |
DK (1) | DK1877409T3 (es) |
DO (1) | DOP2006000096A (es) |
EA (1) | EA012983B1 (es) |
ES (1) | ES2328629T3 (es) |
FR (1) | FR2884821B1 (es) |
GT (1) | GT200600174A (es) |
HR (1) | HRP20090494T1 (es) |
IL (1) | IL186523A0 (es) |
MA (1) | MA29480B1 (es) |
MX (1) | MX2007013084A (es) |
NO (1) | NO20075918L (es) |
PA (1) | PA8671301A1 (es) |
PE (1) | PE20071420A1 (es) |
PL (1) | PL1877409T3 (es) |
PT (1) | PT1877409E (es) |
RS (1) | RS51136B (es) |
SI (1) | SI1877409T1 (es) |
TN (1) | TNSN07360A1 (es) |
TW (1) | TW200718701A (es) |
WO (1) | WO2006114520A2 (es) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8119655B2 (en) | 2005-10-07 | 2012-02-21 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
JP2010505962A (ja) * | 2006-10-09 | 2010-02-25 | 武田薬品工業株式会社 | キナーゼ阻害剤 |
JP2010505961A (ja) * | 2006-10-09 | 2010-02-25 | タケダ サン ディエゴ インコーポレイテッド | キナーゼ阻害剤 |
WO2008063888A2 (en) | 2006-11-22 | 2008-05-29 | Plexxikon, Inc. | Compounds modulating c-fms and/or c-kit activity and uses therefor |
WO2008078100A2 (en) | 2006-12-22 | 2008-07-03 | Astex Therapeutics Limited | Tricyclic amine derivatives as protein tyrosine kinase inhibitors |
CN101679408B (zh) * | 2006-12-22 | 2016-04-27 | Astex治疗学有限公司 | 作为fgfr抑制剂的双环杂环化合物 |
BRPI0814423B1 (pt) | 2007-07-17 | 2022-04-19 | Plexxikon, Inc | Compostos que modulam quinase e composição farmacêutica compreendendo os mesmos |
GB0720038D0 (en) * | 2007-10-12 | 2007-11-21 | Astex Therapeutics Ltd | New compounds |
GB0720041D0 (en) | 2007-10-12 | 2007-11-21 | Astex Therapeutics Ltd | New Compounds |
GB0810902D0 (en) | 2008-06-13 | 2008-07-23 | Astex Therapeutics Ltd | New compounds |
DE102008052943A1 (de) | 2008-10-23 | 2010-04-29 | Merck Patent Gmbh | Azaindolderivate |
AR078033A1 (es) | 2009-04-03 | 2011-10-12 | Plexxikon Inc | Una dispersion solida, que contiene al compuesto {3-[5-(4-(cloro-fenil)-1h-pirrolo[2,3-b]piridina-3-carbonil]-2,4-difluor-fenil}-amida del acido propano-1-sulfonico, composiciones y formulaciones que comprenden a dicha dispersion solida; metodos para fabricar dicha dispersion solida, formas 1 y 2 de |
GB0906472D0 (en) | 2009-04-15 | 2009-05-20 | Astex Therapeutics Ltd | New compounds |
GB0906470D0 (en) | 2009-04-15 | 2009-05-20 | Astex Therapeutics Ltd | New compounds |
US20110030037A1 (en) * | 2009-07-07 | 2011-02-03 | Vadim Olshansky | Zone migration in network access |
US8329724B2 (en) | 2009-08-03 | 2012-12-11 | Hoffmann-La Roche Inc. | Process for the manufacture of pharmaceutically active compounds |
ES2633317T3 (es) | 2009-11-06 | 2017-09-20 | Plexxikon, Inc. | Compuestos y métodos para la modulación de quinasas, e indicaciones para ello |
MA34948B1 (fr) | 2011-02-07 | 2014-03-01 | Plexxikon Inc | Composes et procedes de modulation de kinase, et leurs indications |
TWI558702B (zh) | 2011-02-21 | 2016-11-21 | 普雷辛肯公司 | 醫藥活性物質的固態形式 |
EP2855477A4 (en) * | 2012-05-29 | 2015-11-18 | Merck Sharp & Dohme | BARYARY COMPOUNDS, ISOTOPICALLY MARKED |
US9150570B2 (en) | 2012-05-31 | 2015-10-06 | Plexxikon Inc. | Synthesis of heterocyclic compounds |
US20140275082A1 (en) | 2013-03-14 | 2014-09-18 | Abbvie Inc. | Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
GB201310464D0 (en) * | 2013-06-12 | 2013-07-24 | Lytix Biopharma As | Compounds |
GB201310460D0 (en) * | 2013-06-12 | 2013-07-24 | Lytix Biopharma As | Compounds |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3254843B2 (ja) * | 1993-08-09 | 2002-02-12 | 三菱ウェルファーマ株式会社 | 新規縮合ヘテロ環誘導体 |
US6335342B1 (en) * | 2000-06-19 | 2002-01-01 | Pharmacia & Upjohn S.P.A. | Azaindole derivatives, process for their preparation, and their use as antitumor agents |
GB0115109D0 (en) | 2001-06-21 | 2001-08-15 | Aventis Pharma Ltd | Chemical compounds |
US7427623B2 (en) * | 2001-09-11 | 2008-09-23 | Smithkline Beecham Corporation | 4-Amino-2,3-disubstituted thieno[2,3-d]pyrimidines and pharmacetical compositions thereof |
WO2003028724A1 (en) * | 2001-10-04 | 2003-04-10 | Smithkline Beecham Corporation | Chk1 kinase inhibitors |
US7129225B2 (en) * | 2001-10-22 | 2006-10-31 | The Research Foundation Of State University Of New York | Protection against and treatment of hearing loss |
IL164187A0 (en) * | 2002-03-28 | 2005-12-18 | Eisai Co Ltd | 7-Azaindole derivatives and pharmaceutical compositions containing the same |
FR2878849B1 (fr) | 2004-12-06 | 2008-09-12 | Aventis Pharma Sa | Indoles substitues, compositions les contenant, procede de fabrication et utilisation |
-
2005
- 2005-04-26 FR FR0504173A patent/FR2884821B1/fr not_active Expired - Fee Related
-
2006
- 2006-04-25 PE PE2006000435A patent/PE20071420A1/es not_active Application Discontinuation
- 2006-04-25 AR ARP060101646A patent/AR061386A1/es unknown
- 2006-04-26 RS RSP-2009/0400A patent/RS51136B/sr unknown
- 2006-04-26 DK DK06743743T patent/DK1877409T3/da active
- 2006-04-26 BR BRPI0613161-1A patent/BRPI0613161A2/pt not_active IP Right Cessation
- 2006-04-26 MX MX2007013084A patent/MX2007013084A/es active IP Right Grant
- 2006-04-26 TW TW095114907A patent/TW200718701A/zh unknown
- 2006-04-26 ES ES06743743T patent/ES2328629T3/es active Active
- 2006-04-26 GT GT200600174A patent/GT200600174A/es unknown
- 2006-04-26 DE DE602006007337T patent/DE602006007337D1/de active Active
- 2006-04-26 JP JP2008508258A patent/JP2008539211A/ja active Pending
- 2006-04-26 EA EA200702329A patent/EA012983B1/ru not_active IP Right Cessation
- 2006-04-26 DO DO2006000096A patent/DOP2006000096A/es unknown
- 2006-04-26 PA PA20068671301A patent/PA8671301A1/es unknown
- 2006-04-26 PT PT06743743T patent/PT1877409E/pt unknown
- 2006-04-26 EP EP06743743A patent/EP1877409B1/fr active Active
- 2006-04-26 AU AU2006239105A patent/AU2006239105A1/en not_active Withdrawn
- 2006-04-26 SI SI200630396T patent/SI1877409T1/sl unknown
- 2006-04-26 CN CNA200680014034XA patent/CN101166739A/zh active Pending
- 2006-04-26 KR KR1020077024847A patent/KR20080007229A/ko not_active Application Discontinuation
- 2006-04-26 WO PCT/FR2006/000925 patent/WO2006114520A2/fr active Application Filing
- 2006-04-26 PL PL06743743T patent/PL1877409T3/pl unknown
- 2006-04-26 AT AT06743743T patent/ATE433976T1/de active
- 2006-04-26 CA CA002605744A patent/CA2605744A1/fr not_active Abandoned
-
2007
- 2007-09-21 TN TNP2007000360A patent/TNSN07360A1/en unknown
- 2007-10-09 IL IL186523A patent/IL186523A0/en unknown
- 2007-10-11 US US11/870,640 patent/US7947706B2/en not_active Expired - Fee Related
- 2007-10-22 CR CR9463A patent/CR9463A/es not_active Application Discontinuation
- 2007-11-16 NO NO20075918A patent/NO20075918L/no not_active Application Discontinuation
- 2007-11-22 MA MA30412A patent/MA29480B1/fr unknown
-
2009
- 2009-09-16 HR HR20090494T patent/HRP20090494T1/hr unknown
- 2009-09-16 CY CY20091100957T patent/CY1109369T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GT200600174A (es) | Pirrolopiridinas sustituidas, composiciones que las contienen, proceso de fabricacion y utilizacion | |
GT200800258A (es) | Compuestos de pirrolo-pirimidina y sus usos | |
GT200500226A (es) | Compuestos de aminoheteroarilo sustituidos con pirazol como inhibidores de proteina quinasa | |
GT200600197A (es) | Compuestos y composiciones como inhibidores de proteina quinasa | |
GT200300031A (es) | Indazoles substitutos, composiciones que los contienen, procedimiento de fabricacion y utilizacion | |
GT200500103A (es) | 4-fenilamino-quinazolin-6-il-amidas | |
GT200600430A (es) | Compuestos de carboxiamina y metodos de uso de los mismos | |
GT200500242A (es) | Procesos para la preparaciòn de 2-(2,6-dioxopiperidin-3-il)-1-oxoisoindolinas sustituidas | |
GT200500218A (es) | Derivados de triazolopiridinilsulfanilo como inhibidores de quinasa map p38 | |
GT200500292A (es) | Derivados de 2-amido-4-feniltiazol, su preparacion y su aplicacion en terapeutica | |
GT200700039A (es) | Derivados de triazolopirazina | |
GT200600356A (es) | Mezclas fungicidas que contienen anilidas sustituidas de acido 1-metilpirazol-4-ilcarboxilico. | |
NI200800020A (es) | 7-aza-indazoles sustituidos, composiciones que los contienen, procedimiento de fabricación y utilización. | |
BRPI0611863A2 (pt) | composto, bem como composiÇço e kit compreendendo o mesmo, composto intermediÁrio na preparaÇço do mesmo, mÉtodo para tratamento e uso do mesmo | |
GT200400161A (es) | Piridinonas sustituidas | |
GT200300087A (es) | 2-(2,6-diclorofenil)-diarilimidazoles | |
GT200600306A (es) | Inhibidores de glutamato agrecanasa | |
GT200600205A (es) | Nuevos herbicidas | |
GT200700077A (es) | Compuestos de 4-metilpiridopirimidinona | |
GT200600167A (es) | Derivados de dihidrobenzofurano y usos de los mismos | |
GT200300292A (es) | Derivados de pirimidina para el tratamiento de crecimiento celular anormal | |
GT200800103A (es) | 5-aril isoxazolinas para controlar plagas de invertebrados | |
GT200500159A (es) | (orto-fenil)-anilidas de àcido 1-metil-3-trifluorometil-pirazol-4-carboxìlico y su uso como fungicida | |
GT200300257A (es) | Fungicidas | |
GT200300171A (es) | Derivados de heterobiarilo como inhibidores de metaloproteinasa de la matriz |